Respiratory Medicine
Volume 104, Issue 6 , Pages 780-787, June 2010

Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections☆

  • Charlene M. Prazma

      Affiliations

    • Respiratory Medical Development Center, GlaxoSmithKline, Research Triangle Park, Five Moore Drive, NC 27709, USA
    • ,
  • Kenneth M. Kral

      Affiliations

    • Respiratory Medical Development Center, GlaxoSmithKline, Research Triangle Park, Five Moore Drive, NC 27709, USA
    • ,
  • Nadeem Gul

      Affiliations

    • GlaxoSmithKline, Stockley Park, London, UK
    • ,
  • Steve W. Yancey

      Affiliations

    • Respiratory Medical Development Center, GlaxoSmithKline, Research Triangle Park, Five Moore Drive, NC 27709, USA
    • ,
  • David A. Stempel

      Affiliations

    • Respiratory Medical Development Center, GlaxoSmithKline, Research Triangle Park, Five Moore Drive, NC 27709, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 483 5325; fax: +1 919 483 4300.

Received 19 November 2009; accepted 8 February 2010. published online 08 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was funded by GlaxoSmithKline.

PII: S0954-6111(10)00058-2

doi:10.1016/j.rmed.2010.02.007

Respiratory Medicine
Volume 104, Issue 6 , Pages 780-787, June 2010

Article Tools

* Image Usage & Resolution